---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-23-000033"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2023-06-27T23:59:59+00:00"
generated_at: "2026-06-13T16:10:19.087400+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# iBio appoints Martin Brenner as permanent CEO and Felipe Duran as permanent CFO

## Summary
- Martin Brenner, formerly interim CEO and CSO, appointed permanent CEO; Felipe Duran, formerly interim CFO, appointed permanent CFO, effective June 22, 2023.
- Brenner's base salary set at $507,150, including prior $7,500/month interim stipend; granted 75,833 RSUs vesting over 7 months.
- Duran's compensation unchanged: base salary of $350,000 with 40% target bonus and $140,000 special incentive bonus.
- Board expresses confidence in duo to lead iBio's AI-powered antibody discovery platform and next stage of growth.
- Brenner has leadership experience at major pharma including Pfizer and Merck; Duran previously VP of FP&A at iBio.

## SEC filing metadata
- accession: 0001420720-23-000033
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2023-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072023000033/0001420720-23-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072023000033/ibio-20230622x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-23-000033
- JSON: https://secwatch.observer/filing/0001420720-23-000033.json
- Plain text: https://secwatch.observer/filing/0001420720-23-000033.txt

## Key facts
- Executive change
  Martin Brenner was appointed as Chief Executive Officer at iBio, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: appointed Dr. Martin Brenner its then Interim Chief Executive Officer (CEO), to the position of permanent CEO effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072023000033/0001420720-23-000033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.